Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled Study to Evaluate if Rasagiline Can Improve Depressive Symptoms and Cognitive Function in Non-demented, Idiopathic Parkinson's Disease Patients: ACCORDO Study

NCT01055379 is registered in ClinicalTrials.gov with Lundbeck Italia S.p.A. as lead sponsor.

NCT NCT01055379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01055379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled Study to Evaluate if Rasagiline Can Improve Depressive Symptoms and Cognitive Function in Non-demented, Idiopathic Parkinson's Disease Patients: ACCORDO Study
Lead sponsor
Lundbeck Italia S.p.A.
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2010
Completion date
July 31, 2012
Enrollment
121 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

depressive symptoms, parkinson's disease